ECCMID 2022

ECCMID 2022
April 23-26, 2022
Lisbon, Portugal

32nd European Congress of Clinical Microbiology & Infectious Diseases.

Explore more information for Gilead COVID-19 therapies
Material Type
Filter by Keyword(s)

Filter results with keywords such as:

  • Name of author(s)
  • Disease state
  • Indication
  • Trial phase
  • Trial name
  • Trial date

Note: Multiple keywords can be applied at the same time.

    Results (4)

    Remdesivir treatment for COVID-19 in hospitalized children: CARAVAN interim results

    • Author(s): Ahmed, A
    • veklury
    • COVID-19

    COVID-19 treatment and outcomes in over 850,000 hospitalized patients in the United States: May 2020-December 2021

    • Author(s): Chen, L
    • veklury
    • COVID-19

    Outpatient remdesivir prevents COVID-19 progression in high-risk patients when randomized within 7 days from symptom onset: subanalyses from a phase 3 trial

    • Author(s): Paredes, R
    • veklury
    • COVID-19

    Mortality in 2,310 renal transplant recipients hospitalized for COVID-19: renal allograft function is a clinically dominant predictor of mortality

    • Author(s): Gottlieb, R
    • veklury
    • COVID-19